About
Founded in 2018 in Tel Aviv, Nucleai applies AI to analyze pathology images for medical research and clinical diagnostics.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Founders / core team
Investors
Funding history
- 2024-04$14M
Investors · Debiopharm、Grove Ventures、Section 32、Sanofi、M Ventures、Vertex Ventures Israel、复星锐正
Source · SVTR Weekly #047
Comparable companies· by market
MostSimilar business · Same sector: Life Sciences · Similar total funding
United States
Latest roundTotal raisedDateChina
Latest roundTotal raisedDateEurope
Latest roundTotal raisedDateConfirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.